Pharmacology

• Monoclonal Ab which acts as an epidermal growth factor receptor (EGFR) inhibitor

Adverse Effects

• Bronchospasm/Hoarseness (see Obstructive Lung Disease)
  • Epidemiology: may be severe in 1% of cases
  • Clinical: occurs during IV infusion

References

• xxx